Afrigen teams up with Belgian partner over coronavirus shots
Cape Town-based company signs pact with Univercells Group to develop an mRNA jab
21 June 2022 - 18:15
Cape Town-based Afrigen Biologics has signed an agreement with Belgian Univercells Group to develop a novel mRNA Covid-19 vaccine that is cheaper and easier to store than jabs now on the market.
If successful, this will be the first African-owned coronavirus vaccine, and it will boost the continent’s ambitions to reduce reliance on imports...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.